Quantiphi, a leading AI-first digital engineering company, is proud to announce its inclusion as a strategic delivery partner in Google Cloud’s recent launch of AI-powered solutions for drug discovery and precision medicine in the life sciences industry. Google Cloud’s Target and Lead Identification suite and Multiomics Suite, featuring Quantiphi as a key delivery partner, aims to accelerate scientific breakthroughs and advance patient care.
As a delivery partner in Google Cloud’s ecosystem, Quantiphi joins a select group of expert implementers for the Target and Lead Identification Suite and Multiomics Suite. Quantiphi’s extensive experience in AI-led digital engineering, combined with its deep understanding of the life sciences industry, positions it as a trusted partner for organizations seeking to deploy these solutions at scale.
Google Cloud’s Target and Lead Identification Suite enables life sciences companies to expedite the drug discovery process through in silico drug design. By leveraging technologies such as AlphaFold2 and Vertex AI pipelines, researchers can predict protein structures with unprecedented accuracy and identify potential lead candidates efficiently.
Google Cloud’s Multiomics suite empowers organizations to unlock the potential of precision medicine by transforming complex multi-omics data into actionable insights. By streamlining the analysis of genomic data, designing clinical genomics, and interpreting genetic information, this solution revolutionizes how researchers and data scientists collaborate and discover new paths for treatment.
“We are thrilled to forge this powerful alliance at the forefront of AI and life sciences, catalyzing a revolution in drug discovery and precision medicine,” said Asif Hasan, Co-founder of Quantiphi. “As a strategic delivery partner to Google Cloud, we are excited to bring our AI expertise and deep industry knowledge to accelerate scientific breakthroughs and elevate patient care. Together, we unveil a future where in silico drug design and multiomics data converge to unlock new frontiers of treatment and transform lives.”
“Artificial intelligence has been making inroads in research and drug discovery for over a decade, but now we’re at a turning point,” said Shweta Maniar, global director for Life Sciences Strategy and Solutions, Google Cloud. “We’re bringing together cutting-edge technology like AlphaFold2, Vertex AI, and BigQuery, with partners like Quantiphi who are experts implementing these transformative solutions for life sciences organizations, to help them bring treatments to market faster and bring the industry a step closer to realizing the promise precision medicine.”
SOURCE: PRWeb